1198 related articles for article (PubMed ID: 18386220)
1. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases.
Matesanz N; Lafuente N; Azcutia V; Martín D; Cuadrado A; Nevado J; Rodríguez-Mañas L; Sánchez-Ferrer CF; Peiró C
J Hypertens; 2007 Mar; 25(3):609-18. PubMed ID: 17278978
[TBL] [Abstract][Full Text] [Related]
4. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.
Kou B; Vatish M; Singer DR
Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells.
Yashima R; Abe M; Tanaka K; Ueno H; Shitara K; Takenoshita S; Sato Y
J Cell Physiol; 2001 Aug; 188(2):201-10. PubMed ID: 11424087
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
10. p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis.
Grethe S; Coltella N; Di Renzo MF; Pörn-Ares MI
Biochem Biophys Res Commun; 2006 Sep; 347(3):781-90. PubMed ID: 16843435
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
12. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
[TBL] [Abstract][Full Text] [Related]
13. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
[TBL] [Abstract][Full Text] [Related]
14. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces apoptosis of HUVECs in an in vitro capillary model by activating proapoptotic signal p38 through suppression of ERK1/2.
Eguchi R; Suzuki A; Miyakaze S; Kaji K; Ohta T
Cell Signal; 2007 Jun; 19(6):1121-31. PubMed ID: 17303382
[TBL] [Abstract][Full Text] [Related]
16. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
[TBL] [Abstract][Full Text] [Related]
17. A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells.
Yu J; Eto M; Akishita M; Okabe T; Ouchi Y
Vascul Pharmacol; 2009 Jul; 51(1):21-8. PubMed ID: 19275968
[TBL] [Abstract][Full Text] [Related]
18. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog protein promotes bone marrow-derived endothelial progenitor cell proliferation, migration and VEGF production via PI 3-kinase/Akt signaling pathways.
Fu JR; Liu WL; Zhou JF; Sun HY; Xu HZ; Luo L; Zhang H; Zhou YF
Acta Pharmacol Sin; 2006 Jun; 27(6):685-93. PubMed ID: 16723086
[TBL] [Abstract][Full Text] [Related]
20. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
